By: MyPharmalotID
By the way, to the point of four months, please review this video. http://www.youtube.com/watch?v=1MfVMVQO0Pk
View ArticleBy: Evelyn Pringle
Yea thanks Ed. Again I didn’t mean to single you out. Your site is my favorite on the internet and the one I read the most, so it’s probably just that I end up seeing the news about Provenge here. I’ll...
View ArticleBy: MyPharmalotID
Perhaps those in the media who read this Blog might find the following discussion useful when it comes to describing the benefits of Provenge: Instead of talking about a 4.1-month MEDIAN survival...
View ArticleBy: David Miller
I have a couple of questions, Rhonda: 1. How do you explain the fact 95% of your respondents say they pay for the apheresis separately when this is impossible? Dendreon picks up 100% of this cost and...
View ArticleBy: wired
Am I correct in understanding there is no other FDA approved treatment for this cancer or any cancer that has efficacy equal to the extended median survival of 4.1 months… if there is what is it?
View ArticleBy: LokkoutJoe
Prior to Provenge, the standard of care for this group of patients was Taxotere (docetaxal). Docetaxal showed a 2.1 month survival advantage over the then standard of care. This was a survival rate of...
View ArticleBy: john
Actually, I think the 4 month median survival benefit explains the situation pretty well. If you look at the survival curves in the prescribing information, the percentage of Provenge treated patients...
View ArticleBy: Sheila
Do most insurance providers cover the cost of the provenge vacine, or part of it? Just curious to know what to expect
View Article
